Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair and regeneration. Science. 2017;356:1026–30.
Baddour JA, Sousounis K, Tsonis PA. Organ repair and regeneration: an overview. Birth Defects Res Part C Embryo Today Rev. 2012;96:1–29.
Campana L, Esser H, Huch M, Forbes S. Liver regeneration and inflammation: from fundamental science to clinical applications. Nat Rev Mol Cell Biol. 2021;22:608–24.
Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18:40–55.
Kim W, et al. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. J Clin Investig. 2017;127:137–52.
Huang R, Zhang X, Gracia-Sancho J, Xie W-F. Liver regeneration: cellular origin and molecular mechanisms. Liver Int. 2022;42:1486–95.
Hoffmann K, et al. Markers of liver regeneration-the role of growth factors and cytokines: a systematic review. BMC Surg. 2020;20:31.
Zhang C, Sun C, Zhao Y, Ye B, Yu G. Signaling pathways of liver regeneration: biological mechanisms and implications. iScience. 2024;27:108683.
Hora S, Wuestefeld T. Liver injury and regeneration: current understanding, new approaches, and future perspectives. Cells 2023;12:2129.
Nguyen-Lefebvre AT, et al. Modeling the liver’s regenerative capacity across different clinical conditions. JHEP Rep Innov Hepatol. 2025;7:101465.
Cahill TJ, Choudhury RP, Riley PR. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat Rev Drug Discov. 2017;16:699–717.
Lerman DA, Alotti N, Ume KL, Péault B. Cardiac repair and regeneration: the value of cell therapies. Eur Cardiol. 2016;11:43–48.
Frangogiannis NG. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Investig. 2017;127:1600–12.
Xue M, Jackson CJ. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care. 2015;4:119–36.
Schütte JP, et al. Cell type–specific secretome analysis reveals liver-heart crosstalk in HFpEF. Circ Res. 2025;136:1516–8.
Sun H, et al. Cirrhosis promotes cardiac fibrosis development by inhibiting Notch1 in cardiac fibroblasts. JACC Basic Transl Sci. 2025;10:612–31.
Gieseck RL, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18:62–76.
Julier Z, Park AJ, Briquez PS, Martino MM. Promoting tissue regeneration by modulating the immune system. Acta Biomater. 2017;53:13–28.
Rurik JG, Aghajanian H, Epstein JA. Immune cells and immunotherapy for cardiac injury and repair. Circ Res. 2021;128:1766–79.
Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015;15:117–29.
Yap J, et al. Macrophages in cardiac remodeling after myocardial infarction. Nat Rev Cardiol. 2023;20:373–85.
de Couto G. Macrophages in cardiac repair: environmental cues and therapeutic strategies. Exp Mol Med. 2019;51:1–10.
Yu Y, et al. Macrophages play a key role in tissue repair and regeneration. PeerJ. 2022;10:e14053.
Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181–94.
Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306–21.
Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3:51–62.
Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol. 2009;86:513–28.
Gomes RN, Manuel F, Nascimento DS. The bright side of fibroblasts: molecular signature and regenerative cues in major organs. npj Regen Med. 2021;6:43.
Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151–66.
Ivey MJ, Tallquist MD. Defining the cardiac fibroblast. Circ J. 2016;80:2269–76.
Van Linthout S, Miteva K, Tschöpe C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res. 2014;102:258–69.
Huang E, et al. The roles of immune cells in the pathogenesis of fibrosis. Int J Mol Sci. 2020;21:5203.
Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245–57.
Budi EH, Schaub JR, Decaris M, Turner S, Derynck R. TGF-β as a driver of fibrosis: physiological roles and therapeutic opportunities. J Pathol. 2021;254:358–73.
Waterhouse NJ, et al. A central role for bid in granzyme B-induced apoptosis *. J Biol Chem. 2005;280:4476–82.
Velotti F, Barchetta I, Cimini FA, Cavallo MG. Granzyme B in inflammatory diseases: apoptosis, inflammation, extracellular matrix remodeling, epithelial-to-mesenchymal transition and fibrosis. Front Immunol. 2020;11:587581.
Epelman S, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 2014;40:91–104.
Li G, et al. Optogenetic vagal nerve stimulation attenuates heart failure by limiting the generation of monocyte-derived inflammatory CCRL2+ macrophages. Immunity. 2025;58:1847–1861.e1849.
McLellan MA, et al. High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy. Circulation. 2020;142:1448–63.
Pierre SV, Xie Z. The Na,K-ATPase receptor complex. Cell Biochem Biophys. 2006;46:303–15.
Shoshani L, et al. The polarized expression of Na+,K+-ATPase in epithelia depends on the association between β-subunits located in neighboring cells. Mol Biol Cell. 2005;16:1071–81.
Tokhtaeva E, et al. Epithelial junctions depend on intercellular trans-interactions between the Na,K-ATPase β₁ subunits. J Biol Chem. 2011;286:25801–12.
Rajasekaran SA, et al. Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol-Gastrointest Liver Physiol. 2007;292:G124–G133.
Rajasekaran SA, et al. Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell. 2001;12:3717–32.
Rajasekaran SA, Rajasekaran AK. Na,K-ATPase and epithelial tight junctions. FBL. 2009;14:2130–48.
Kikuchi K, Poss KD. Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol. 2012;28:719–41.
Garbern JC, Lee RT. Heart regeneration: 20 years of progress and renewed optimism. Dev Cell. 2022;57:424–39.
Gong R, Jiang Z, Zagidullin N, Liu T, Cai B. Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration. Signal Transduct Target Ther. 2021;6:31.
Abu Rmilah A, et al. Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev Dev Biol. 2019;8:e340.
Crowl JT, et al. Tissue-resident memory CD8+ T cells possess unique transcriptional, epigenetic and functional adaptations to different tissue environments. Nat Immunol. 2022;23:1121–31.
Masopust D, Soerens AG. Tissue-resident T cells and other resident leukocytes. Ann Rev Immunol. 2019;37:521–46.
Hiebert PR, Wu D, Granville DJ. Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice. Cell Death Differ. 2013;20:1404–14.
Hendel A, Granville DJ. Granzyme B cleavage of fibronectin disrupts endothelial cell adhesion, migration and capillary tube formation. Matrix Biol. 2013;32:14–22.
Shen Y, et al. Granzyme B deficiency protects against angiotensin II–induced cardiac fibrosis. Am J Pathol. 2016;186:87–100.
Bayer AL, et al. Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction. Nat Cardiovasc Res. 2024;3:970–86.
Kaye J. CD160 and BTLA: LIGHTs out for CD4+ T cells. Nat Immunol. 2008;9:122–4.
Lai C, et al. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma. J Immunother Cancer. 2021;9:e001807.
Tan CL, et al. CD160 stimulates CD8+ T-cell responses and is required for optimal protective immunity to Listeria monocytogenes. ImmunoHorizons. 2018;2:238–50.
Liu S, Zhang W, Liu K, Wang Y. CD160 expression on CD8+ T cells is associated with active effector responses but limited activation potential in pancreatic cancer. Cancer Immunol Immunother. 2020;69:789–97.
Rodriguez-Barbosa JI, et al. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT. Cell Mol Immunol. 2019;16:679–82.
Zhao M, et al. Targeting fibrosis: mechanisms and clinical trials. Signal Transduct Target Ther. 2022;7:206.
Zhao X, Chen J, Sun H, Zhang Y, Zou D. New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction. Cell Biosci. 2022;12:117.
Liu B-q, et al. XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7. EMBO Rep. 2023;24:e55387.
Trapnell C, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381–6.